Inventor · disambiguated record
Olivier Soula
Also filed as: SOULA OLIVIER
33 granted patents·30 pending applications·278 citations·filing 1998–2023
96Inventor score
Top patents by PatentIndex Score
63 records- 0194USRE46686EPharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applicationsFLAMEL IRELAND LTD·Filed 2016·Granted Jan 30, 2018·36 cites·74 claims
- 0293US9457089B2Highly concentrated aqueous protein solution with reduced viscosityADOCIA·Filed 2013·Granted Oct 4, 2016·13 cites·21 claims
- 0392US9493583B2Anionic polysaccharides functionalized by a hydrophobic acid derivativeCHARVET RICHARD·Filed 2010·Granted Nov 15, 2016·9 cites·44 claims
- 0492US8679540B2Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applicationsBONNET-GONNET CECILE·Filed 2007·Granted Mar 25, 2014·53 cites·35 claims
- 0589US9089476B2Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5SOULA OLIVIER·Filed 2012·Granted Jul 28, 2015·9 cites·25 claims
- 0687US9492467B2Rapid-acting insulin formulation comprising an oligosaccharideADOCIA·Filed 2014·Granted Nov 15, 2016·3 cites·32 claims
- 0787US8426382B2Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivativeSOULA REMI·Filed 2010·Granted Apr 23, 2013·5 cites·26 claims
- 0887US6133199AProcess and compositions promoting biological effectiveness of exogenous chemical substances in plantsMONSANTO CO·Filed 1998·Granted Oct 17, 2000·42 cites·39 claims
- 0986US8084045B2Pharmaceutical formulations for the prolonged release of active principle(s) and their applicationsPOULIQUEN GAUTHIER·Filed 2004·Granted Dec 27, 2011·37 cites·24 claims
- 1085US9795678B2Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compoundADOCIA·Filed 2015·Granted Oct 24, 2017·3 cites·27 claims
- 1183US8241620B2Complex polymere amphiphile-PDGFDAHRI-CORREIA LATIFA·Filed 2011·Granted Aug 14, 2012·17 cites·17 claims
- 1281US8367640B2Complex consisted of a polysaccharide and an HBPADOCIA·Filed 2009·Granted Feb 5, 2013·3 cites·12 claims
- 1380US10583175B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2017·Granted Mar 10, 2020·2 cites·33 claims
- 1480US9700599B2Rapid-acting insulin formulation comprising a substituted anionic compoundADOCIA·Filed 2013·Granted Jul 11, 2017·3 cites·14 claims
- 1580US9233993B2N-phosphonomethylglycine guanidine derivative saltsBRINKER RONALD J·Filed 2010·Granted Jan 12, 2016·2 cites·24 claims
- 1679US10485851B2Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acidADOCIA·Filed 2017·Granted Nov 26, 2019·3 cites·16 claims
- 1779US8389661B2Complexes between an amphiphilic polymer and an osteogenic protein belonging to the family of BMPsSOULA GERARD·Filed 2008·Granted Mar 5, 2013·3 cites·26 claims
- 1879US8293255B2Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof, in particular for therapeutic purposesSOULA OLIVIER·Filed 2006·Granted Oct 23, 2012·1 cites·27 claims
- 1978US10383918B2Compositions in the form of an injectable aqueous solution comprising human glucagon and a statistical co-polyamino acidADOCIA·Filed 2017·Granted Aug 20, 2019·3 cites·15 claims
- 2076US10548952B2Injectable solution at pH7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5, a prandial insulin and/or a gastrointestinal hormone, and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2017·Granted Feb 4, 2020·2 cites·36 claims
- 2176US10383920B2Injectable solution at pH 7 comprising at least one basal insulin the pI of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2017·Granted Aug 20, 2019·2 cites·18 claims
- 2276US8629124B2Dextran functionalized by hydrophobic amino acidsSOULA GERARD·Filed 2008·Granted Jan 14, 2014·2 cites·11 claims
- 2374US6500783B1Process and compositions promoting biological effectiveness of exogenous chemical substances in plantsMONSANTO TECHNOLOGY LLC·Filed 1999·Granted Dec 31, 2002·21 cites·49 claims
- 2473US9018190B2Functionalized oligosaccharidesCHARVET RICHARD·Filed 2012·Granted Apr 28, 2015·1 cites·4 claims
- 2571US8546356B2Administration form of osteogenic protein complexesSOULA OLIVIER·Filed 2009·Granted Oct 1, 2013·2 cites·46 claims
- 2670US10792335B2Rapid-acting insulin composition comprising a substituted citrateADOCIA·Filed 2016·Granted Oct 6, 2020·1 cites·21 claims
- 2767US2024115663A1Compositions comprising at least an insulin and an amylin receptor agonist for treating diabetes, in a patient/person having a bmi of more than 28 kg/m² and/or an hba1c of more than 7.6%ADOCIA·Filed 2023·Application pending·0 cites
- 2864US2011027363A1Nouvelle forme d'administration de proteines osteogeniquesADOCIA·Filed 2009·Application pending·0 cites
- 2963US2018311316A1Injectable solution at ph 7 comprising at least one basal insulin whose pi is between 5.8 and 8.5ADOCIA·Filed 2018·Application pending·0 cites
- 3062US9775355B2Guanidine derivative compoundsMONSANTO TECHNOLOGY LLC·Filed 2015·Granted Oct 3, 2017·0 cites·36 claims
- 3162US2015314003A2Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymerADOCIA·Filed 2014·Application pending·0 cites
- 3261US10449256B2Injectable solution at pH 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymerADOCIA·Filed 2018·Granted Oct 22, 2019·0 cites·10 claims
- 3361US2014235536A1Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is comprised in 5.8 and 8.5 and an anionic compound bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2014·Application pending·0 cites
- 3460US2009291114A1Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic supportADOCIA·Filed 2009·Application pending·0 cites
- 3558US8017156B2Long-acting colloidal insulin formulation and its preparationFLAMEL TECH SA·Filed 2005·Granted Sep 13, 2011·0 cites·12 claims
- 3658US2018236085A1Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is comprised in 5.8 and 8.5 and an anionic compound bearing carboxylate charges and hydrophobic radicalsADOCIA·Filed 2018·Application pending·0 cites
- 3758US2009291113A1Osteogenic composition comprising a growth factor, a soluble cation salt and organic supportADOCIA·Filed 2009·Application pending·0 cites
- 3858US2013231281A1Rapid acting insulin formulation comprising an oligosaccharideADOCIA·Filed 2012·Application pending·0 cites
- 3957US2008175921A1Colloidal formulation of long-acting insulin and its preparationCONSTANCIS ALAIN·Filed 2007·Application pending·0 cites
- 4057US2010137456A1Polysaccharides functionalized by tryptophan derivativesADOCIA·Filed 2009·Application pending·0 cites
- 4157US2013245246A1Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivativeADOCIA·Filed 2013·Application pending·0 cites
- 4256US10335489B2Injectable solution at pH 7 comprising at least one basal insulin the pi of which is between 5.8 and 8.5 and a substituted co-polyamino acidADOCIA·Filed 2015·Granted Jul 2, 2019·0 cites·39 claims
- 4354US2010167984A1Complex between human insulin and an amphiphilic polymer and use of this complex in the preparation of a fast-acting human insulin formulationADOCIA·Filed 2009·Application pending·0 cites
- 4454US2017182131A9Injectable solution at ph 7 comprising at least one basal insulin whose pi is between 5.8 and 8.5ADOCIA·Filed 2015·Application pending·0 cites
- 4553US2010167991A1Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivativeADOCIA·Filed 2009·Application pending·0 cites
- 4653US2008293635A1Angiogenic compositionADOCIA·Filed 2008·Application pending·0 cites
- 4752US9198971B2Injectable solution at pH 7 comprising at least one basal insulin the pI of which is between 5.8 and 8.5 and a substituted co-polyamino acidADOCIA·Filed 2013·Granted Dec 1, 2015·0 cites·30 claims
- 4850US2015216977A1Stable pharmaceutical composition, comprising an aqueous solution of an antibody-derived therapeutically active proteinADOCIA·Filed 2013·Application pending·0 cites
- 4949US2011014189A1Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituentsADOCIA·Filed 2009·Application pending·0 cites
- 5049US2009221805A1Complex polymere amphiphile-PDGFPROTEINS AND PEPTIDES MAN·Filed 2006·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Olivier Soula files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →